HRP20040617B1 - Derivati 5-(piridin-3-il)-1-azabiciklo[3.2.1]oktana, njihova priprava i primjena u nekim terapijskim sredstvima - Google Patents

Derivati 5-(piridin-3-il)-1-azabiciklo[3.2.1]oktana, njihova priprava i primjena u nekim terapijskim sredstvima

Info

Publication number
HRP20040617B1
HRP20040617B1 HRP20040617AA HRP20040617A HRP20040617B1 HR P20040617 B1 HRP20040617 B1 HR P20040617B1 HR P20040617A A HRP20040617A A HR P20040617AA HR P20040617 A HRP20040617 A HR P20040617A HR P20040617 B1 HRP20040617 B1 HR P20040617B1
Authority
HR
Croatia
Prior art keywords
sub
groups
azabicyclo
pyridin
preparation
Prior art date
Application number
HRP20040617AA
Other languages
English (en)
Croatian (hr)
Inventor
Frédéric Galli
Odile Leclerc
Alistair Lochead
Alain Nedelec
Original Assignee
Sanofi-Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Aventis filed Critical Sanofi-Aventis
Publication of HRP20040617A2 publication Critical patent/HRP20040617A2/hr
Publication of HRP20040617B1 publication Critical patent/HRP20040617B1/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Addiction (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
HRP20040617AA 2002-01-07 2003-01-03 Derivati 5-(piridin-3-il)-1-azabiciklo[3.2.1]oktana, njihova priprava i primjena u nekim terapijskim sredstvima HRP20040617B1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0200109A FR2834511B1 (fr) 2002-01-07 2002-01-07 Derives de 5-(pyridin-3-yl)-1-azabicyclo[3.2.1]octane, leur preparation et leur application en therapeutique
PCT/FR2003/000004 WO2003057697A1 (fr) 2002-01-07 2003-01-03 Derives de 5-(pyridin-3-yl)-1-azabicyclo [3.2.1] octane, leur preparation et leur application en therapeutique

Publications (2)

Publication Number Publication Date
HRP20040617A2 HRP20040617A2 (en) 2004-10-31
HRP20040617B1 true HRP20040617B1 (hr) 2012-10-31

Family

ID=8871176

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20040617AA HRP20040617B1 (hr) 2002-01-07 2003-01-03 Derivati 5-(piridin-3-il)-1-azabiciklo[3.2.1]oktana, njihova priprava i primjena u nekim terapijskim sredstvima

Country Status (35)

Country Link
US (2) US7223750B2 (enExample)
EP (1) EP1465893B1 (enExample)
JP (1) JP4402957B2 (enExample)
KR (1) KR100977332B1 (enExample)
CN (2) CN1911928A (enExample)
AR (2) AR038098A1 (enExample)
AT (1) ATE355290T1 (enExample)
AU (1) AU2003216777B2 (enExample)
BR (1) BR0306707A (enExample)
CA (1) CA2471628C (enExample)
CO (1) CO5590914A2 (enExample)
CY (1) CY1106580T1 (enExample)
DE (1) DE60312123T2 (enExample)
DK (1) DK1465893T3 (enExample)
EA (1) EA007793B1 (enExample)
EC (1) ECSP045176A (enExample)
ES (1) ES2281631T3 (enExample)
FR (1) FR2834511B1 (enExample)
HR (1) HRP20040617B1 (enExample)
IL (2) IL162524A0 (enExample)
IS (1) IS2470B (enExample)
MA (1) MA27165A1 (enExample)
ME (2) MEP24408A (enExample)
MX (1) MXPA04006630A (enExample)
NO (1) NO329309B1 (enExample)
NZ (1) NZ533793A (enExample)
PL (1) PL216665B1 (enExample)
PT (1) PT1465893E (enExample)
RS (1) RS50921B (enExample)
SI (1) SI1465893T1 (enExample)
TN (1) TNSN04120A1 (enExample)
TW (1) TWI336703B (enExample)
UA (1) UA77229C2 (enExample)
WO (1) WO2003057697A1 (enExample)
ZA (1) ZA200405002B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9902007D0 (en) * 1999-01-30 1999-03-17 Thomas Carpentry Services Limi Improvements relating to door frames
FR2834511B1 (fr) * 2002-01-07 2004-02-13 Sanofi Synthelabo Derives de 5-(pyridin-3-yl)-1-azabicyclo[3.2.1]octane, leur preparation et leur application en therapeutique
FR2889701B1 (fr) * 2005-08-12 2007-10-05 Sanofi Aventis Sa Derives de 5-pyridinyl-1-azabicyclo[3.2.1]octane, leur preparation en therapeutique.
FR2889847B1 (fr) * 2005-08-18 2007-10-05 Sanofi Aventis Sa Derives de 5-pyridazinyl-1-azabicyclo[3.2.1]octave, leur preparation en therapeutique.
FR2912404B1 (fr) * 2007-02-09 2009-04-10 Sanofi Aventis Sa Derives d'azabicycloalkane,leur preparation et leur application en therapeutique.
KR101925971B1 (ko) 2011-01-28 2018-12-06 에스케이바이오팜 주식회사 피리돈 유도체 및 이를 포함하는 약학적 조성물
KR101928505B1 (ko) 2011-01-28 2018-12-12 에스케이바이오팜 주식회사 피리돈 유도체 및 이를 포함하는 약학적 조성물
KR20200083976A (ko) 2017-11-03 2020-07-09 알콘 인코포레이티드 눈 장애의 치료를 위한 아자바이시클로 및 디아제핀 유도체

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5817679A (en) * 1993-04-01 1998-10-06 University Of Virginia 7-Azabicyclo 2.2.1!-heptane and -heptene derivatives as cholinergic receptor ligands
WO2000034284A1 (fr) * 1998-12-04 2000-06-15 Sanofi-Synthelabo Derives de 2,5-diazabicyclo[2.2.1]heptane, leur preparation et leur application en therapeutique
WO2000034279A1 (fr) * 1998-12-04 2000-06-15 Sanofi-Synthelabo Derives de 1,4-diazabicyclo[3.2.2]nonane, leur preparation et leur application en therapeutique

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7474794A (en) 1993-07-22 1995-02-20 E.I. Du Pont De Nemours And Company Arthropodicidal azacyclic heterocycles
FR2834511B1 (fr) * 2002-01-07 2004-02-13 Sanofi Synthelabo Derives de 5-(pyridin-3-yl)-1-azabicyclo[3.2.1]octane, leur preparation et leur application en therapeutique

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5817679A (en) * 1993-04-01 1998-10-06 University Of Virginia 7-Azabicyclo 2.2.1!-heptane and -heptene derivatives as cholinergic receptor ligands
WO2000034284A1 (fr) * 1998-12-04 2000-06-15 Sanofi-Synthelabo Derives de 2,5-diazabicyclo[2.2.1]heptane, leur preparation et leur application en therapeutique
WO2000034279A1 (fr) * 1998-12-04 2000-06-15 Sanofi-Synthelabo Derives de 1,4-diazabicyclo[3.2.2]nonane, leur preparation et leur application en therapeutique

Also Published As

Publication number Publication date
EP1465893B1 (fr) 2007-02-28
CN1911928A (zh) 2007-02-14
UA77229C2 (uk) 2006-11-15
US7223750B2 (en) 2007-05-29
CN1276921C (zh) 2006-09-27
CO5590914A2 (es) 2005-12-30
EP1465893A1 (fr) 2004-10-13
RS59904A (sr) 2006-10-27
AR038098A1 (es) 2004-12-29
US20070185137A1 (en) 2007-08-09
US7585974B2 (en) 2009-09-08
KR100977332B1 (ko) 2010-08-20
HK1066547A1 (en) 2005-03-24
ZA200405002B (en) 2006-05-31
MXPA04006630A (es) 2004-11-10
CA2471628C (en) 2011-03-22
JP2005514422A (ja) 2005-05-19
IS2470B (is) 2008-12-15
CN1612876A (zh) 2005-05-04
EA007793B1 (ru) 2007-02-27
DE60312123D1 (de) 2007-04-12
JP4402957B2 (ja) 2010-01-20
US20050020568A1 (en) 2005-01-27
TWI336703B (en) 2011-02-01
FR2834511B1 (fr) 2004-02-13
RS50921B (sr) 2010-08-31
DE60312123T2 (de) 2007-09-13
WO2003057697A1 (fr) 2003-07-17
ES2281631T3 (es) 2007-10-01
MEP24408A (en) 2010-10-10
TW200305413A (en) 2003-11-01
IL162524A0 (en) 2005-11-20
NZ533793A (en) 2007-01-26
IS7322A (is) 2004-06-16
DK1465893T3 (da) 2007-06-04
HRP20040617A2 (en) 2004-10-31
NO329309B1 (no) 2010-09-27
AU2003216777A1 (en) 2003-07-24
CY1106580T1 (el) 2012-01-25
ECSP045176A (es) 2004-08-27
ME00213B (me) 2011-02-10
PL370065A1 (en) 2005-05-16
NO20042846L (no) 2004-09-21
AR086573A2 (es) 2014-01-08
FR2834511A1 (fr) 2003-07-11
EA200400770A1 (ru) 2004-12-30
IL162524A (en) 2010-05-17
PT1465893E (pt) 2007-05-31
BR0306707A (pt) 2005-02-09
TNSN04120A1 (fr) 2006-06-01
KR20040077705A (ko) 2004-09-06
SI1465893T1 (sl) 2007-08-31
AU2003216777B2 (en) 2008-10-02
MA27165A1 (fr) 2005-01-03
CA2471628A1 (en) 2003-07-17
PL216665B1 (pl) 2014-04-30
ATE355290T1 (de) 2006-03-15

Similar Documents

Publication Publication Date Title
ATE353318T1 (de) Neue indolderivate mit affinität zum 5-ht6- rezeptor
CA2317589A1 (en) Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
AR021534A1 (es) Derivados de 1,4-diazabiciclo[3.2.2]nonano, su preparacion y su aplicacion en terapeutica
JP2008525417A5 (enExample)
WO1999028304A3 (en) Pdgf receptor kinase inhibitory compounds, their preparation and compositions
BRPI0412695A (pt) derivados de quinolina e quinazolina dotados de afinidade para receptores do tipo 5ht1
BRPI0414450A (pt) derivados de diazabicicloalcano substituìdos como ligandos nos receptores de alfa 7 acetilcolina nicotìnica
ATE302775T1 (de) Carbolinderivate
DK1163207T3 (da) Forbedret fremgangsmåde til fremstillingen af ikke-hygroskopiske salte af L(-)-carnitin
HRP20040617B1 (hr) Derivati 5-(piridin-3-il)-1-azabiciklo[3.2.1]oktana, njihova priprava i primjena u nekim terapijskim sredstvima
DE60020967D1 (de) Kristalle von lansoprazole
TR199902590T2 (xx) Birle�ik 5HT1A 5HT1B ve 5HT1D resept�r antagonist aktivitesi olan indol t�revleri.
CY1108815T1 (el) Διαδοχικη χορηγηση cpt-11 και πολυπεπτιδιου apo-2l
EA200701853A1 (ru) Производные циклопентапиридина и тетрагидрохинолина
ATE465995T1 (de) N-'(1,5-diphenyl-1h-pyrazol-3- yl)sulfonamidderivate mit affinität zum cb1- rezeptor
ATE346067T1 (de) Carbolinderivate
ATE249457T1 (de) Indolderivate und ihre verwendung als serotoninrezeptor-liganden
SE0101765D0 (sv) Novel compounds
ATE370952T1 (de) Neue verbindungen
BRPI0612189A2 (pt) composto, composiÇço farmacÊutica, mÉtodo para ligar receptores opiàides
SE0101766D0 (sv) Novel compounds
KR950025039A (ko) 신규의 치환된 피리딘 이미다졸 유도체 및 그의 제조방법
TW200626548A (en) Heterocyclic compound and optical recording material
AR036408A1 (es) Tieno[2,3-d]pirimidinas sustituidas con glicina con actividad agonista combinada de lh y fsh
MXPA05012116A (es) Derivados de diarilmetilideno piperidina y su uso como agonistas del receptor opioide delta.

Legal Events

Date Code Title Description
A1OB Publication of a patent application
PNAN Change of the applicant name, address/residence

Owner name: SANOFI-AVENTIS, FR

ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20161214

Year of fee payment: 15

PBON Lapse due to non-payment of renewal fee

Effective date: 20180103